Key Takeaways
- Cannabis use disorder affects approximately 10 percent of regular users, with higher rates among those who begin in adolescence.
- Colorado's legal market has produced concentrates with THC levels exceeding 90 percent, dramatically different from the plant material of prior decades.
- Polysubstance use involving cannabis, alcohol, and stimulants has increased across the Denver metro area since legalization.
- CDHS data shows increasing treatment admissions where cannabis is a contributing substance, even when not the primary drug of concern.
- Effective treatment for co-occurring cannabis and other substance use disorders requires integrated dual-diagnosis programming.
A Decade of Legal Marijuana in Colorado: The Treatment Perspective
When Colorado voters approved Amendment 64 in 2012, the state became a national laboratory for marijuana legalization. The policy debate focused largely on criminal justice reform, tax revenue, and personal liberty. A decade later, the behavioral health community has accumulated substantial real-world data on how legal cannabis access intersects with broader substance use patterns.
This is not an anti-legalization argument. The policy question is settled in Colorado and increasingly across the nation. The clinical question, however, remains urgent: how does ubiquitous, highly potent, commercially marketed cannabis affect individuals who are vulnerable to or already struggling with substance use disorders?
CDHS and the Colorado School of Public Health have published data showing that while overall cannabis use rates in Colorado have risen modestly post-legalization, the more significant shifts involve potency escalation, adolescent use patterns, and co-occurring use with other substances. These trends have direct implications for treatment providers and families across the Front Range.
Cannabis use disorder is recognized as a clinical diagnosis in the DSM-5. It is characterized by continued use despite negative consequences, tolerance, withdrawal symptoms, and inability to reduce use. Approximately 3 in 10 current cannabis users meet criteria for the disorder.
The Potency Problem: Today's Cannabis Is Not the Same Drug
One of the most clinically relevant developments in Colorado's legal cannabis market is the dramatic increase in THC potency. Understanding potency changes is essential for assessing risk and educating patients and families.
The average THC concentration in Colorado flower products has risen from roughly 15 percent to over 25 percent since legalization. More significantly, concentrates including waxes, shatters, and vape cartridges commonly test between 70 and 95 percent THC. These products bear little pharmacological resemblance to the marijuana of the 1990s or even the 2010s.
Health Consequences of High-Potency Use
Research published by UC Health and other Colorado-based institutions links high-potency cannabis use to increased rates of psychotic episodes, cannabinoid hyperemesis syndrome, and accelerated development of cannabis use disorder. Emergency department visits related to cannabis have risen significantly in Denver and along the I-25 corridor since concentrate products became widely available.
- Cannabis-related ER visits in Colorado have approximately tripled since legalization.
- Cannabinoid hyperemesis syndrome, virtually unknown before high-potency products, now accounts for thousands of annual ER visits statewide.
- Adolescents using high-potency products show faster progression to cannabis use disorder compared to flower-only users.
- Psychotic symptoms, including paranoia and hallucinations, are dose-dependent and significantly more common with concentrate use.
Co-Occurring Cannabis and Other Substance Use
The more pressing concern from a treatment standpoint is not isolated cannabis use but rather its role in polysubstance patterns. In Colorado, cannabis increasingly appears as a co-occurring substance alongside alcohol, opioids, and stimulants, complicating treatment and recovery.
CDHS treatment admission data reveals that cannabis is listed as a secondary or tertiary substance in a growing percentage of admissions where alcohol or methamphetamine is the primary concern. This pattern suggests that for many individuals, cannabis is part of a broader substance use picture rather than an isolated behavior.
Mixing cannabis with alcohol significantly increases impairment and the risk of dangerous decision-making. Colorado has seen a marked increase in DUI cases involving both substances detected simultaneously.
Cannabis and Alcohol: The Most Common Combination
The most frequently observed polysubstance pattern in Colorado involves concurrent cannabis and alcohol use. Denver's bar and nightlife culture in neighborhoods like LoDo and Capitol Hill normalizes simultaneous use. Clinically, this combination amplifies cognitive impairment, increases the likelihood of blackouts, and makes it harder for individuals to recognize problematic drinking patterns.
Cannabis and Opioid Co-Use
The relationship between cannabis and opioid use in Colorado is complex. Some advocates argue that cannabis can serve as a harm reduction tool, replacing opioids for chronic pain. While there is limited evidence supporting this for some individuals, the clinical reality is that many opioid-dependent patients add cannabis to their substance use rather than substituting it. Treatment providers along the Front Range increasingly encounter patients using both substances regularly.
Cannabis and Stimulant Use
Methamphetamine and cocaine users in the Denver metro area frequently report using cannabis to manage stimulant side effects including anxiety, insomnia, and the crash phase. While this self-medication logic seems intuitive, it creates a polysubstance dependency pattern that requires more complex clinical intervention.
Cannabis Use Disorder: Diagnosis and Clinical Reality
Despite widespread cultural minimization, cannabis use disorder is a real and increasingly common clinical diagnosis. The DSM-5 outlines 11 criteria for the disorder, and individuals meeting 2 or more within a 12-month period receive a mild, moderate, or severe diagnosis.
Colorado treatment providers report that patients presenting with cannabis use disorder frequently express surprise at the diagnosis. Years of messaging around cannabis safety, combined with legal access and social normalization, create cognitive barriers to recognizing problematic use.
Withdrawal Symptoms
Cannabis withdrawal is formally recognized in the DSM-5 and can be significant enough to drive relapse. Symptoms typically emerge within 24 to 72 hours of cessation and may persist for 1 to 3 weeks. Understanding withdrawal helps patients prepare and reduces the temptation to use cannabis to alleviate discomfort.
- Irritability, anxiety, and restlessness are the most commonly reported withdrawal symptoms.
- Sleep disturbance, including vivid dreams and insomnia, can persist for several weeks.
- Decreased appetite and mild nausea may occur, particularly in heavy concentrate users.
- Depression and anhedonia during withdrawal can mimic co-occurring mood disorders and require careful clinical assessment.
There are currently no FDA-approved medications specifically for cannabis use disorder or cannabis withdrawal. Treatment relies on behavioral interventions, sleep hygiene, and supportive care.
Treatment Approaches for Cannabis-Involved Substance Use Disorders
Treating individuals whose substance use includes cannabis requires nuanced clinical judgment. For some patients, cannabis may be the primary concern. For others, it is one element of a broader polysubstance pattern that must be addressed comprehensively.
Effective programs incorporate motivational interviewing to address ambivalence about cannabis cessation, cognitive behavioral therapy to identify and modify use patterns, and contingency management to reinforce abstinence. When cannabis use co-occurs with other substances, integrated treatment that addresses all substances simultaneously produces better outcomes than sequential approaches.
If you or a loved one is struggling with cannabis alongside other substances, comprehensive dual-diagnosis treatment is essential. Call Trust SoCal at (949) 280-8360 to discuss an integrated treatment plan.
Local Colorado Resources
Denver Health and UC Health both offer outpatient programs that address cannabis use disorder within broader substance use treatment. CDHS funds community-based providers throughout the Denver metro area and Colorado Springs that provide sliding-scale outpatient treatment. However, residential programs specifically designed for cannabis-involved polysubstance use are rare in Colorado.
The Case for Out-of-State Treatment
Colorado's permissive cannabis environment presents a unique challenge for recovery. Legal dispensaries operate on nearly every commercial block in Denver, with billboards and advertisements reinforcing normalization. For individuals for whom cannabis is a gateway to broader polysubstance use, removing themselves from this environment during early recovery can be a critical success factor.
Trust SoCal's location in Fountain Valley, California, provides geographic separation from Colorado's cannabis culture while offering comprehensive dual-diagnosis programming in a temperate, recovery-supportive setting.
Impact on Adolescents and Young Adults
Perhaps the most concerning trend identified by CDHS is the impact of normalized cannabis access on Colorado's youth. While the legal purchase age is 21, adolescent access has not demonstrably decreased post-legalization, and the social acceptability of use has increased significantly.
Young adults in Denver's Capitol Hill and university-adjacent neighborhoods face particular pressure. Cannabis use is deeply embedded in social life, and the line between recreational and problematic use is blurred by cultural acceptance. Young brains are more vulnerable to the effects of high-potency THC, with regular use before age 25 associated with cognitive impairment, reduced motivation, and increased risk for psychotic disorders.
Warning Signs in Young People
Parents and educators in Colorado should be alert to signs that cannabis use has crossed from experimental to problematic.
- Declining academic or work performance that coincides with increased use.
- Social withdrawal from non-using friends and activities.
- Escalation from flower to concentrates or edibles for stronger effects.
- Using alone or first thing in the morning to manage mood or anxiety.
- Defensive or hostile reactions when use is questioned.
Moving Forward: Balanced Policy and Clinical Honesty
Colorado's experience with legal cannabis provides valuable data for the nation. The treatment community has a responsibility to communicate honestly about both the benefits of decriminalization and the real clinical risks of high-potency, widely accessible cannabis products.
If you or a family member in Colorado is struggling with cannabis use alone or in combination with other substances, help is available. Trust SoCal offers comprehensive assessment and personalized treatment planning. Call (949) 280-8360 for a confidential consultation.
Colorado's Healthy Kids Colorado Survey indicates that perceived risk of regular cannabis use among high school students has declined by nearly 50 percent since legalization. Prevention messaging must evolve to address this shift.
Medical Review Board, MD, ABAM
Medical Director & Reviewer
